Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-15
2011-11-15
Fetterolf, Brandon (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S234200, C514S249000, C514S250000, C544S061000, C544S118000, C544S231000, C544S251000, C544S238000
Reexamination Certificate
active
08058270
ABSTRACT:
Disclosed is the use of a compound of general Formula (1),optionally in form of its tautomers, racemates, enantiomers, diastereomers and the mixtures thereof and optionally in form of the pharmacologically acceptable acid addition salts, solvates, hydrates, polymorphs, physiologically functional derivatives or prodrugs thereof, for the preparation of a pharmaceutical composition for the treatment of diseases characterized by abnormal cell proliferation in a human or non-human mammalian body by inhibition of polo like kinases as mitotic regulators.
REFERENCES:
patent: 4957922 (1990-09-01), Lammens et al.
patent: 5167949 (1992-12-01), Ferrand et al.
patent: 5198547 (1993-03-01), Bailey et al.
patent: 5424311 (1995-06-01), Billhardt-Troughton et al.
patent: 5698556 (1997-12-01), Chan
patent: 6096924 (2000-08-01), Studer et al.
patent: 6156766 (2000-12-01), Arita et al.
patent: 6174895 (2001-01-01), Kleinman
patent: 6605255 (2003-08-01), Kroll et al.
patent: 6806272 (2004-10-01), Bauer et al.
patent: 6861422 (2005-03-01), Hoffmann et al.
patent: 6875868 (2005-04-01), Bonnert et al.
patent: 7238807 (2007-07-01), Duran et al.
patent: 7241889 (2007-07-01), Hoffmann et al.
patent: 7332491 (2008-02-01), Grauert et al.
patent: 7371753 (2008-05-01), Stadtmueller et al.
patent: 7414053 (2008-08-01), Grauert et al.
patent: 7439358 (2008-10-01), Linz et al.
patent: 7547780 (2009-06-01), Grauert et al.
patent: 7625899 (2009-12-01), Hoffmann et al.
patent: 7626019 (2009-12-01), Duran et al.
patent: 7629460 (2009-12-01), Grauert et al.
patent: 7700769 (2010-04-01), Grauert et al.
patent: 7723517 (2010-05-01), Grauert et al.
patent: 7728134 (2010-06-01), Linz et al.
patent: 7750152 (2010-07-01), Hoffman et al.
patent: 7759347 (2010-07-01), Hoffmann
patent: 7759485 (2010-07-01), Linz et al.
patent: 7807831 (2010-10-01), Grauert et al.
patent: 7816530 (2010-10-01), Grauert
patent: 2002/0183292 (2002-12-01), Pairet et al.
patent: 2002/0183293 (2002-12-01), Banerjee et al.
patent: 2003/0130286 (2003-07-01), Denny et al.
patent: 2004/0029885 (2004-02-01), Bauer et al.
patent: 2004/0147524 (2004-07-01), Bauer et al.
patent: 2004/0176380 (2004-09-01), Hoffmann et al.
patent: 2005/0014760 (2005-01-01), Hoffmann et al.
patent: 2005/0014761 (2005-01-01), Hoffmann et al.
patent: 2005/0148501 (2005-07-01), Palmer et al.
patent: 2005/0159414 (2005-07-01), Nickolaus et al.
patent: 2005/0165010 (2005-07-01), Nickolaus et al.
patent: 2006/0004014 (2006-01-01), Hoffmann et al.
patent: 2006/0009457 (2006-01-01), Hoffmann et al.
patent: 2006/0025411 (2006-02-01), Hoffmann et al.
patent: 2006/0035902 (2006-02-01), Linz et al.
patent: 2006/0035903 (2006-02-01), Mohr et al.
patent: 2006/0046989 (2006-03-01), Grauert et al.
patent: 2006/0047118 (2006-03-01), Stadtmueller et al.
patent: 2006/0052383 (2006-03-01), Grauert et al.
patent: 2006/0058311 (2006-03-01), Munzert et al.
patent: 2006/0074088 (2006-04-01), Munzert et al.
patent: 2006/0079503 (2006-04-01), Schwede et al.
patent: 2007/0208027 (2007-09-01), Duran et al.
patent: 2007/0213528 (2007-09-01), Duran et al.
patent: 2007/0213529 (2007-09-01), Duran et al.
patent: 2007/0213530 (2007-09-01), Duran et al.
patent: 2007/0213531 (2007-09-01), Duran et al.
patent: 2007/0213534 (2007-09-01), Duran et al.
patent: 2007/0219369 (2007-09-01), Duran et al.
patent: 2008/0108812 (2008-05-01), Grauert et al.
patent: 2008/0113992 (2008-05-01), Grauert et al.
patent: 2008/0171747 (2008-07-01), Hoffman et al.
patent: 2008/0177066 (2008-07-01), Linz et al.
patent: 2008/0194818 (2008-08-01), Grauert et al.
patent: 2008/0221099 (2008-09-01), Munzert et al.
patent: 2008/0293944 (2008-11-01), Hoffmann et al.
patent: 2008/0319190 (2008-12-01), Grauert et al.
patent: 2008/0319192 (2008-12-01), Grauert et al.
patent: 2008/0319193 (2008-12-01), Grauert et al.
patent: 2009/0018333 (2009-01-01), Grauert et al.
patent: 2009/0023733 (2009-01-01), Cage et al.
patent: 2009/0030004 (2009-01-01), Linz et al.
patent: 2009/0124628 (2009-05-01), Hoffmann et al.
patent: 2009/0143379 (2009-06-01), Mohr et al.
patent: 2009/0238828 (2009-09-01), Munzert et al.
patent: 2009/0280115 (2009-11-01), Maier et al.
patent: 2009/0298840 (2009-12-01), Linz et al.
patent: 2010/0029642 (2010-02-01), Hoffmann et al.
patent: 2010/0249412 (2010-09-01), Linz et al.
patent: 2010/0249458 (2010-09-01), Linz et al.
patent: 2010/0280037 (2010-11-01), Linz et al.
patent: 2010/0324288 (2010-12-01), Hoffmann et al.
patent: 2458699 (2003-03-01), None
patent: 2517020 (2004-09-01), None
patent: 2517010 (2004-11-01), None
patent: 2576290 (2006-02-01), None
patent: 143478 (1985-06-01), None
patent: 347146 (1989-12-01), None
patent: 399856 (1990-11-01), None
patent: 429149 (1991-05-01), None
patent: 2287583 (2007-12-01), None
patent: 2002125451 (2004-01-01), None
patent: 9609045 (1996-03-01), None
patent: 9634867 (1996-11-01), None
patent: 9636597 (1996-11-01), None
patent: 9811893 (1998-03-01), None
patent: 01/19825 (2001-03-01), None
patent: 0170741 (2001-09-01), None
patent: 0178732 (2001-10-01), None
patent: 02057261 (2002-07-01), None
patent: 02076954 (2002-10-01), None
patent: 02076985 (2002-10-01), None
patent: 03020722 (2003-03-01), None
patent: 03093249 (2003-11-01), None
patent: 2004014899 (2004-02-01), None
patent: 2004076454 (2004-09-01), None
patent: 2004093848 (2004-11-01), None
patent: 2005067935 (2005-07-01), None
patent: 2006/018182 (2006-02-01), None
patent: 2006/018221 (2006-02-01), None
patent: 2006018185 (2006-02-01), None
patent: 2006018220 (2006-02-01), None
patent: 2006018221 (2006-02-01), None
patent: 2006021378 (2006-03-01), None
patent: 2007090844 (2007-08-01), None
patent: 2009019205 (2009-02-01), None
Eschenbach, J. Nat. Cancer Inst., vol. 94, No. 11,790-792, Jun. 5, 2002.
Ohio Department of Health; Brain & Other Central Nervous System Cancer in Ohio, 1997-2001; Sep. 2004; pp. 1-4.
Voskoglou-Nomikos et al; Clincial Predictive Value of the in Vitro Cell Line, Human Xenograft, and Mouse Allograft Preclinical Cancer Models; Clinical Cancer Research; Sep. 15, 2003; vol. 9; pp. 4227-4239.
Cecil Textbook of Medicine; 20th Edition; vol. 1; W.B. Saunders Co. 1997; pp. 1004-1009.
Journal of the National Cancer Institute; Jun. 5, 2002; vol. 94; No. 11; pp. 790-792.
ACPS Meeting, Background Information. “Scientific considerations of plymorphism in pharmaceutical solids: abbreviated new drug applications”. Oct. 2002.
Ahlenius, T. List of cardiovascular disorder/diseases. Ahlenius, Karolinska Institutet. Stockholm, Sweden. Cardiovascular Diseases, p. 1-34, Apr. 2007.
Ahmad, N. “Polo-like kinase (Plk) 1: a novel target for the treatment of prostate cancer”. Dept of Dermatology, Univ. Wisconsin, pp. 3-5.
BBC News/Health, Killer Breast Cancern Therapy Hope, www.newsvote.bbc/co./uk, downloaded Mar. 26, 2009.
Blain, S. W. et al., “Differential interaction of the cyclin-dependent kinase (Cdk) Inhibitor p27KIP with cyclin A-Cdk2 and cyclin D2-Cdk4”. The Journal of Biological Chemistry, vol. 272, No. 41, Issue Oct. 10, 1997, pp. 25862-25872.
Dipolar aprotic solvent. Exhibit A, IUPAC Compendium of Chemical Terminology, 2nd Edition, 1997.
Doerwald, F.Z. “Side reactions in organice synthesis”. 2005.
Eurasian Opinion, Appln No. 2007/00389/28, Maly Slatoustinsky per., d.10, kv.15, 101000 Moscow, Russia, “EVROMARKPAT”, 2007.
Ferrand, G., et al., “Synthesis and potential antiallergic activity of new pteridinones and related compounds”. Eur. J. Med. Chem, 31, 1996, pp. 273-280. XP-2246920.
Ghandi, L., et al., “An Open-Label Phase II Trial of the PLK Inhibitor BI 2536 in Patients with Sensitive Relapse Small Cell Lung Cancer”. ASCO Meeting 2009.
Giron, G. “Thernal analysis and calorimetric methods in the characterization of plymorphs and solvates”. Thermochimica Acta 248, 1995, pp. 1-59.
Goodman-Gilman's “The Pharmacological Basis of Therapeutics”. Ninth edition, 1996, pp. 1225-1271.
Ito, Y., et al., “Polo-like kinase 1 (PLK) expression is associated with cell proliferative activity and cdc2 e
Munzert Gerd
Steegmaier Martin
Boehringer Ingelheim International GmbH
Bottino Anthony P.
Fetterolf Brandon
Gembeh Shirley V
Morris Michael P.
LandOfFree
Dihydropteridinones for the treatment of cancer diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydropteridinones for the treatment of cancer diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydropteridinones for the treatment of cancer diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4308107